DINESH

Rainbow Children Medicare

Industry: Healthcare
Latest CMP 1,314
Today's Change ▼ -3.91%
52-Week High / Low 1,599 | 1,101
Price Date: 30-Sep-2026
Recommendation Buy
Target Price 1,950
Expected Upside 21.8%
Forecast Horizon 2 Years
Historical CAGR Not Available
1,000 Invested —
Today's Value —
Investment Period < 5 Years

Stock Snapshot

Post Results Return
-0.5%
Neutral Market Reaction
1-Year Target Price
1,743
2-Year Target Price
1,950
52-Week High / Low
1,599 / 1,101
20-Day Return
-8.3%
Market Cap (Cr.)
13,348
Current PE
56.2
P/BV Ratio
8.1
Dividend Yield
0.2%
Industry PE
60.9

Price Performance

Vista Outlook

Basis of our Recommendation

Rainbow Children’s Medicare is poised for a significant growth trajectory, transitioning from an aggressive capacity expansion phase to a focus on operational efficiency and monetization. Management's commentary highlights strong volume growth and a strategic hub-and-spoke model aimed at capturing high-value medical tourism and tertiary care demand in under-penetrated regions. Despite anticipated near-term margin pressures due to new hospital commissions, the company is well-positioned to leverage its expanded footprint, with a target of 20% annual revenue growth supported by a robust pipeline of new facilities. Vista's financial outlook reflects stable revenue growth, although margins may face challenges in the short term. The healthcare sector's favorable dynamics, including rising insurance coverage and demand for organized care, bolster this outlook. However, execution risks related to project delays and competitive pressures warrant close monitoring. Over the next 12-24 months, key opportunities include the successful ramp-up of new facilities and expansion into high-demand markets, while headwinds may arise from margin pressures and regulatory challenges

👍 Why We Like This Stock

  • Strong volume growth and strategic expansion into high-demand markets support revenue targets
  • Management's focus on operational efficiency and digital transformation enhances competitive positioning
  • Rising insurance coverage and demand for specialized healthcare services provide a favorable market backdrop

⚠ Things To Watch Out For

  • Near-term margin pressures due to the costs associated with new hospital commissions
  • Execution risks related to project delays and geographic concentration in Southern India
  • Competitive pressures from government institutions and potential regulatory challenges

Key Parameters

Balance Sheet Strength
Stable Financial Structure
Market Share
Stable
Industry Outlook
Weakening
Analyst View
Strong Buy
Dividend History
Consistent
FII Holdings
Reducing

Financial Snapshot

View Technicals Analysis →
Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 1,297 1,516 1,703 1,920 2,243
Profit Before Tax (Cr.) 287 322 360 402 477
PBT Margin 22.2% 21.2% 21.1% 21.0% 21.3%
Net Profit (Cr.) 212 236 263 295 348
Earnings Per Share 20.7 23.2 25.7 28.9 34.2

Analyst Recommendations

Broker Recommendation Target Price Date
Moneycontrol ▲ Overweight nan 04-Sep-2026
Anand Rathi ▲ Buy 1,750 04-Aug-2026
Prabhudas Liladhar ▲ Buy 1,900 04-Aug-2026
JPMorgan ▲ Buy 2,000 03-Aug-2026
IDBI Capital ▲ Buy 1,786 31-Jul-2026
Axis Securities ▲ Buy 1,617 13-Jul-2026
Choice Equity ▲ Buy 1,650 03-Jun-2026
HSBC ▲ Buy 1,400 21-Apr-2026
Consensus Recommendation ▲ Strong Buy
Consensus Target 1,860
Coverage 8 Analysts
Analysts' Viewpoint
Rainbow Children's Medicare is leveraging its specialized focus on mother-and-child healthcare to capitalize on favorable demographic trends and rising insurance penetration. The company's aggressive capacity expansion plan, including new facilities in key regions like Mumbai and Central India, aims to double bed capacity over five years. This growth strategy, supported by a debt-free balance sheet, positions Rainbow for significant earnings potential. However, analysts note risks related to execution in new geographies and maintaining premium pricing amidst competitive pressures. The successful ramp-up of new facilities is crucial for unlocking operating leverage and achieving projected revenue growth.

Company Overview

Show Company Profile

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.